Synapse - Works

Results (116149)

Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis

Meeting Abstract

Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Comprehensive tumour genomic and transcriptomic analyses

Meeting Abstract

Ravaud, A.; Martini, J. F.; Ching, K.; Staehler, M.; Magheli, A.; Escudier, B.; Mu, X. J.; Valota, O.; Lin, X.; Motzer, R. J.
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti-PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)

Meeting Abstract

Rischin, D.; Lim, A. M.; Schmults, C. D.; Khushalani, N. I.; Hughes, B. G.; Schadendorf, D.; Dunn, L. A.; Chang, A. L. S.; Hauschild, A.; Ulrich, C.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours

Meeting Abstract

Schram, A. M.; Drilon, A.; Macarulla Mercade, T.; O'Reilly, E. M.; Rodon, J. A.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C. H.; Lam, Y. C. J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Analysis of BRCA genes and homologous recombination deficiency (HRD) scores in tumours from patients (pts) with metastatic breast cancer (mBC) in the OlympiAD trial

Meeting Abstract

Robson, M.; Lai, Z.; Dearden, S.; Barrett, J. C.; Harrington, E. A.; Timms, K.; Lanchbury, J.; Wu, W.; Allen, A.; Goessl, C.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Prognostic and predictive factors from the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (aHCC)

Meeting Abstract

Meyer, T.; Kelley, R. K.; Mangeshkar, M.; Cheng, A. L.; El-Khoueiry, A. B.; Abou-Alfa, G. K.
Annals of Oncology (2019)

Fulltext@MSK | Save

Prospective study evaluating white adipose tissue inflammation and clinicopathologic features in endometrial cancer

Meeting Abstract

Moukarzel, L. A.; Stylianou, A.; Wu, M.; Nobre, S. P.; Abu-Rustum, N. R.; Broach, V.; Giri, D. D.; Iyengar, N. M.; Weigelt, B.; Makker, V.
Annals of Oncology (2019)

Fulltext@MSK | Save

Impact of the IDEA study on clinical practice for stage III colon cancer patients: A French GERCOR - FFCD - GI UNICANCER national survey

Meeting Abstract

Ouali, K.; Cohen, R.; Turpin, A.; Neuzillet, C.; Rousseau, B.; Garcia-Larnicol, M. L.; Tournigand, C.; Samalin, E.; Taieb, J.; André, T.
Annals of Oncology (2019)

Fulltext@MSK | Save

cfDNA is an acceptable but insufficient means of characterizing FGFR3 mutation in patients with metastatic urothelial cancer (mUC)

Meeting Abstract

Pal, S. K.; Bajorin, D. F.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; Burris, H. A.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)

Meeting Abstract

Moore, K.; Oza, A.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Farias-Eisner, R.; Banerjee, S.; Murphy, C.; Tanyi, J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save